Related references
Note: Only part of the references are listed.Prediction of tumour necrosis fractions using metabolic and volumetric F-18-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma
Hyung Jun Im et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
Matt Vanderhoek et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer
Luca Guerra et al.
ABDOMINAL IMAGING (2011)
Early 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography May Identify a Subset of Patients With Estrogen Receptor-Positive Breast Cancer Who Will Not Respond Optimally to Preoperative Chemotherapy
Andrea A. Martoni et al.
CANCER (2010)
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma
Hyun Woo Chung et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer
Ho Yun Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis
Colleen M. Costelloe et al.
SKELETAL RADIOLOGY (2010)
Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma
M. S. Kim et al.
ANNALS OF ONCOLOGY (2009)
[F-18]-Fluorodeoxy-D-Glucose-Positron Emission Tomography Response Is Associated With Outcome for Extremity Osteosarcoma in Children and Young Adults
Douglas S. Hawkins et al.
CANCER (2009)
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Amandeep Kumar et al.
EUROPEAN RADIOLOGY (2009)
Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRI
Gi Jeong Cheon et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Repeatability of F-18-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
Linda M. Velasquez et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
F-18-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
Colleen M. Costelloe et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET
Zhaoming Ye et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas:: Interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors
Matthias R. Benz et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
An Examination of the Efficacy of the 8 cm Maximal Tumor Diameter Cutoff for the Subdivision of AJCC Stage II Osteosarcoma Patients
Min Suk Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients
Min Suk Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Treatment effects in pediatric soft tissue and bone tumors - Practical considerations for the pathologist
CM Coffin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography
DS Hawkins et al.
CANCER (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Evaluation of chemotherapy response in primary bone tumors with F-18FDG positron emission tomography compared with histologically assessed tumor necrosis
C Franzius et al.
CLINICAL NUCLEAR MEDICINE (2000)